This section contains information about Galapagos NV’s business for stockholders, potential investors, financial analysts and media.
Do you want to receive our press releases?
Volgt huidige Chief Executive Officer en medeoprichter Onno van de Stolpe op, na geplande pensionering Erkende, inspirerende leider in de industrie met uitzonderlijke R&D en…
Succeeds current Chief Executive Officer and co-founder Onno van de Stolpe, following planned retirement Recognized as inspirational industry leader with exceptional R&D as well as…
Mechelen, België; 18 januari 2022; 22.01 CET; Galapagos NV (Euronext & Nasdaq: GLPG) maakt vandaag bekend dat het Medicines and Healthcare products Regulatory Agency (MHRA) de…
Mechelen, Belgium; 18 January 2022; 22.01 CET; Galapagos NV (Euronext & Nasdaq: GLPG) announced today that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted a marketing…
Mechelen, België; 13 januari 2022, 22.01 CET; gereglementeerde informatie – Galapagos NV (Euronext & NASDAQ: GLPG) kondigt vandaag aan dat haar raad van toezicht 30.000…
Mechelen, Belgium; 13 January 2022, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its supervisory board created 30,000 subscription rights…
Mechelen, Belgium; 6 January 2022, 15.30 CET – Galapagos NV (Euronext & NASDAQ: GLPG) will participate in the 40th Annual J.P. Morgan Healthcare Conference on…
Mechelen, België; 3 december 2021, 22.01 CET; gereglementeerde informatie – Galapagos NV (Euronext & NASDAQ: GLPG) kondigt een kapitaalverhoging aan als gevolg van de uitoefening van…
Mechelen, Belgium; 3 December 2021, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from subscription right…
Mechelen, België; 22 november 2021, 22.01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) kondigt de voltooiing aan van de rekrutering in de MANGROVE fase 2-studie…
Mechelen, Belgium; 22 November 2021, 22.01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) announces completion of recruitment in the MANGROVE Phase 2 trial with investigational…